ЕПААМ - Евразийская профессиональная ассоциация аддиктивной медицины

EPAAM - Eurasian Professional Association of Addiction Medicine


The Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence. A Randomized Clinical Noninferiority Trial

A new publication in the journal of the American Medical Association JAMA Psychiatry on the use of extended-release naltrexone for the treatment of opioid-dependent individuals.

At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine

Ukraine’s regional leadership role over a decade on HIVprevention and treatment for people who inject drugs(PWIDs) is now at a crossroads. Recent policy decisionsand restrictive practices are hindering access to andretention of PWIDs in evidence-based treatmentprogrammes. At this juncture, Ukraine must redress thegaps and barriers in HIV policy and service provisionfor PWIDs.

A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment

Background: HIV incidence in Central Asia is rising rapidly. People who inject drugs (PWIDs) contribute greatest to the epidemic, with more than a quarter of all HIV cases being in the criminal justice system (CJS). This review assembled and aggregated recent data on drug-related health problems and respective healthcare services in the CJS of Central Asia and the Republic of Azerbaijan.Methods: Online databases and published literature (peer-reviewed and gray) were reviewed. Additionally, prison officials in the 6 countries were invited to participate in a survey and prison administrators from Kazakhstan, Kyrgyzstan and Tajikistan completed it.